Q BioMed Announces Updates on Commercialization of Non-Opioid Metastatic Cancer Pain Drug
11 juil. 2019 08h32 HE
|
Q BioMed Inc.
NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is pleased to announce the latest updates on its non-opioid therapy for the debilitating...